-lim-
idiospecific
ocrelizumab
-o-
reagin
heterophil antibody
atezolizumab
Forssman antibody
conatumumab
heterophile antibody
-ab
panitumumab
drozitumab
immunospecific
evolocumab
siltuximab
alloantibody
sulesomab
biciromab
robatumumab
zolimomab
oleclumab
immunoprobe
heterophile
bezlotoxumab
olendalizumab
Ab
bococizumab
onartuzumab
dacetuzumab
-a-
monoclonal
pancytokeratin
iratumumab
antigenic
antiantibody
antigenomic
agonistic monoclonal antibody
tabalumab
antisynthetase
matuzumab
inotuzumab ozogamicin
intrabody
countercorrelated
lintuzumab
brentuximab
polyantibody
-i-
ABO antibodies
immunonaive